Xconomy.com -- Targeted Genetics, the Seattle-based developer of gene therapies, said today in its quarterly financial report that it “must raise additional capital” to remain in business beyond this month.
Xconomy.com -- Targeted Genetics, the Seattle-based developer of gene therapies, said today in its quarterly financial report that it “must raise additional capital” to remain in business beyond this month.
